If you purchase this report now and we update it in next 100 days, get it free!
Key Insights
• The United Kingdom operates a predominantly publicly funded healthcare system through the National Health Service, complemented by a substantial private medical insurance market and a meaningful layer of patient out-of-pocket spending. Total healthcare expenditure reached approximately £345 billion in 2025, equivalent to 11.4% of GDP, with government-financed healthcare accounting for 81% of the total at £280 billion. Healthcare fintech in the UK serves the financial workflows that connect NHS reimbursement, private insurance claims, self-pay patient payments, and the administrative machinery that supports them.
• The private medical insurance market provides a significant private-payer layer. According to Association of British Insurers data, approximately 14% of UK adults now hold private medical insurance, equating to 7.6 million people, up from 6.7 million in 2020. The market recorded approximately £8.1 billion in premium in 2025, with employers bearing the majority of the cost and insured admissions reaching record levels as NHS waiting lists remain elevated.
• Out-of-pocket spending is concentrated in dental care, prescription charges in England, optical services, and over-the-counter medicines. Out-of-pocket payments accounted for 14.1% of total health expenditure in 2025, or approximately £49 billion, according to provisional Office for National Statistics estimates. While the UK’s out-of-pocket share is low by international standards, it is sufficient to sustain a structured patient financing market for private treatment and elective procedures.
• Digital payment and invoicing infrastructure is advancing through public-sector modernization. NHS suppliers have been required to submit structured e-invoices in Peppol BIS 3.0 format since June 2022, and the UK Government has committed £49 million to embed open banking into the Gov.UK Pay platform, which is used by NHS teams and more than 1,000 public sector services to accept digital payments. This infrastructure creates the rails for faster patient payments, automated reconciliation, and embedded financing at the point of care.
Market Outlook
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
• According to the Bonafide Research report, “United Kingdom Healthcare Fintech Market Outlook, 2031,” published by Bonafide Research, the UK healthcare fintech market is anticipated to add to more than 26 Billion by 2026-31. This growth reflects sustained demand for provider billing and revenue cycle modernization, private insurance claims automation, patient financing for self-pay and elective treatment, and the digitalization of public-sector payment and invoicing workflows.
• Provider revenue cycle and payment fintech is expected to remain a foundational segment. NHS trusts and private providers are investing in billing accuracy, claims validation, and cash-flow management as financial pressure intensifies, and the existing Peppol-based e-invoicing infrastructure provides a standardized digital backbone for further automation of invoice generation, transmission, and reconciliation.
• Patient care financing is expected to expand as private hospital groups deepen their partnerships with regulated lenders and embed financing options into patient pathways. The model is already well established, with 0% promotional periods and terms extending to 60 months, and it is likely to extend beyond elective surgery into diagnostics, dental care, fertility treatment, and preventive health services.
• Consumer-directed healthcare accounts and embedded payment platforms are expected to grow as employers and private insurers seek flexible benefit structures that combine insurance coverage with spending accounts and digital payment tools. The scale of employer-funded private medical insurance more than two-thirds of the £8.1 billion premium market creates a natural addressable base for account-linked payment and benefit disbursement platforms.
• Open banking and real-time payment infrastructure are expected to reshape patient payment and reimbursement workflows. The integration of open banking into Gov.UK Pay, combined with the existing Peppol e-invoicing infrastructure, is expected to reduce manual reconciliation, accelerate settlement, and enable embedded financing at the point of care.
Market Dynamics
Driver: NHS Financial Pressure and the Administrative Cost of Reimbursement
The UK healthcare fintech market is being shaped by the financial strain on the NHS and the administrative complexity of reimbursement across public and private payers. NHS trusts are under pressure to improve revenue realization, reduce claim denials, and accelerate cash collection, and the projected funding gap for the NHS and adult social care, which is estimated to reach £22 billion by 2030/31, intensifies the case for billing automation and revenue cycle analytics. Private providers that contract with the NHS face a dual administrative burden: they must manage NHS reimbursement workflows alongside private insurance claims and self-pay patient payments, creating demand for integrated billing and payment platforms that can handle multiple payer types within a single financial workflow. The existing Peppol e-invoicing mandate for NHS suppliers adds a compliance driver, requiring providers and suppliers to maintain structured digital invoice capabilities.
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Sikandar Kesari
Research Analyst
Challenge: Fragmented Provider Landscape and Variation Across Devolved Health Systems
A significant challenge facing the UK healthcare fintech market is the fragmentation of the provider landscape and the variation in health system administration across England, Scotland, Wales, and Northern Ireland. Healthcare is a devolved matter, and while the NHS is publicly funded across the UK, reimbursement rules, prescription charges, and administrative processes differ by nation. Prescription charges, for example, apply in England but have been abolished in Scotland, Wales, and Northern Ireland, creating different patient payment workflows and different financing needs. The private provider market is also fragmented, with a concentrated tier of large hospital groups and a long tail of independent clinics and specialty practices, each with different levels of digital maturity and different integration requirements. These structural differences increase the cost of deploying standardized fintech solutions across the UK and slow cross-nation scaling.
Trend: Embedded Patient Finance and Public-Sector Payment Modernization
The UK healthcare fintech market is experiencing a pronounced shift toward embedded patient finance and the modernization of public-sector payment infrastructure. Patient financing is already embedded in provider workflows at scale: Spire Healthcare, Circle Health Group, Nuffield Health, and Ramsay Health Care all offer finance plans through regulated lenders, with 0% promotional periods, terms extending to 60 months, and loan amounts from £350 to £25,000. At the same time, the Government is modernizing public-sector payments through open banking. The £49 million tender to embed open banking into Gov.UK Pay is intended to enable citizens to pay directly through their banking apps, using real-time payment rails, across more than 1,000 public sector services, including NHS trusts. This infrastructure is expected to reduce administrative complexity, lower payment processing costs, and enable faster reconciliation for patient payments and public reimbursement.
Policies
Don't pay for what you don't need. Save 30%
Customise your report by selecting specific countries or regions
• The National Health Service Act and associated NHS legislation establish the statutory framework for NHS financing, provider reimbursement, and patient charges. NHS England oversees commissioning and financial performance, and NHS Shared Business Services administers the e-invoicing platform used by NHS suppliers.
• The UK e-invoicing mandate for NHS suppliers, effective since June 2022, requires all invoices submitted to NHS Shared Business Services to be submitted electronically via the NHS e-invoicing platform or Peppol, using structured Peppol BIS 3.0 formats, with mandatory e-Ordering for NHS trusts. The UK Government has also announced that mandatory e-invoicing for VAT will apply from April 2029, extending structured digital invoicing beyond the NHS into the broader business economy.
• The Association of British Insurers provides industry data and standards for private medical insurance, and the Financial Conduct Authority regulates consumer credit and patient financing products, including the medical loans offered through hospital partnerships.
• The UK Government’s open banking initiative, delivered through Gov.UK Pay, establishes the policy framework for embedding open banking into public-sector payments, including NHS payments, with the objective of reducing administrative burden and improving the citizen payment experience.
Segment Analysis
United Kingdom Healthcare Fintech Market By Solution
• Provider Revenue Cycle and Payment Fintech: A foundational segment encompassing medical billing, claims submission, denial management, and payment processing for NHS trusts, private hospital groups, and independent providers. The segment is driven by NHS financial pressure, the administrative complexity of managing claims across public and private payers, and the compliance requirements of the NHS e-invoicing mandate. Private providers that contract with the NHS must maintain billing workflows that can handle both NHS reimbursement and private insurance claims, creating demand for integrated platforms that support multiple payer types.
• Patient Care Financing: A maturing segment driven by self-pay patients and private treatment. Major hospital groups offer regulated finance plans through lenders such as Chrysalis Finance and Omni Capital, with 0% interest promotional periods, terms extending to 60 months, and loan amounts from £350 to £25,000. The model is embedded directly into provider workflows, and it is extending beyond elective surgery into diagnostics, dental care, and fertility treatment.
• Consumer-Directed Healthcare Accounts and Embedded Payment Platforms: An emerging segment as employers and private insurers explore flexible benefit structures and digital payment tools. The scale of employer-funded private medical insurance more than two-thirds of the £8.1 billion premium market creates an addressable base for account-linked payment and benefit disbursement platforms, and open banking integration through Gov.UK Pay provides the infrastructure for faster, lower-cost payment flows.
United Kingdom Healthcare Fintech Market By Economic Buyer
• Patients and Individual Consumers: A major economic buyer group, reflecting the scale of out-of-pocket spending approximately £49 billion, or 14.1% of total health expenditure and the growth of patient financing for private treatment and elective procedures. Out-of-pocket spending is concentrated in dental care, prescription charges, optical services, and over-the-counter medicines, and it provides the demand base for financing and digital payment solutions.
• Healthcare Providers: A significant economic buyer group, encompassing NHS trusts, private hospital groups, and independent clinics. Providers invest in billing automation, revenue cycle management, and patient payment tools to address NHS financial pressure, manage multi-payer reimbursement complexity, and improve cash flow. Private hospital groups are also embedding patient financing into their workflows, creating a direct link between provider operations and fintech adoption.
United Kingdom Healthcare Fintech Market By Deployment Mode
• Cloud-Based: Cloud-based deployment is prominent across provider billing, patient financing, and payment platforms, driven by the need for scalability, lower upfront infrastructure costs, and integration with NHS e-invoicing and open banking rails. Cloud adoption is particularly strong among independent clinics and specialty practices that lack the capital and IT staff to maintain on-premises financial systems.
• Hybrid: Hybrid deployment combines on-premises and cloud infrastructure, allowing NHS trusts and large private hospital groups to keep sensitive financial and patient data locally while using cloud services for analytics, patient engagement, and billing automation. Hybrid models are relevant for organizations navigating data residency, NHS compliance, and integration with legacy financial systems while seeking the scalability of cloud analytics.
United Kingdom Healthcare Fintech Market Economics
• Healthcare fintech pricing in the UK varies by solution segment and provider size. Provider billing and RCM platforms typically charge per-provider subscription fees plus transaction fees for claims submission and remittance processing. Patient financing platforms earn origination and servicing fees, often structured as a percentage of the financed amount, and the 0% promotional periods are typically subsidized by the provider or recovered through higher interest rates after the promotional period. Embedded payment platforms earn transaction fees and interchange revenue on account-linked card and open banking payments.
• The economic case for billing and RCM automation is anchored in cash acceleration and administrative cost reduction. NHS financial pressure, reflected in the £2.5 billion gross deficit in 2025/26 plans before support funding, creates urgency around revenue realization and cash-flow management, and the existing Peppol e-invoicing infrastructure provides a standardized digital backbone for further automation.
• Patient financing economics are shaped by procedure mix, credit risk, and provider partnerships. The model converts self-pay demand into paid treatment, generating origination and servicing revenue for the lender while improving provider cash realization. The availability of 0% promotional periods and terms extending to 60 months makes financing accessible to a broad patient population, and the embedded nature of the offering integrated directly into hospital workflows reduces customer acquisition costs for lenders.
Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031
Aspects covered in this report
• Healthcare Fintech Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation
By Solution
• Provider Revenue Cycle and Payment Fintech
• Payer Claims and Payment Automation Fintech
• Patient Care Financing
• Health Insurance Premium Financing
• Consumer-Directed Healthcare Accounts and Benefit Payment Platforms
• Healthcare Financial Management and Working Capital Fintech
By Economic Buyer
• Healthcare Providers
• Healthcare Payers
• Patients and Individual Consumers
• Employers and Plan Sponsors
By Deployment Mode
• Cloud-Based
• On-Premises
• Hybrid
Table of Contents
1. Executive Summary
2. Market Structure
2.1. Market Considerate
2.2. Assumptions
2.3. Limitations
2.4. Abbreviations
2.5. Sources
2.6. Definitions
3. Research Methodology
3.1. Secondary Research
3.2. Primary Data Collection
3.3. Market Formation & Validation
3.4. Report Writing, Quality Check & Delivery
4. United Kingdom Geography
4.1. Population Distribution Table
4.2. United Kingdom Macro Economic Indicators
5. Market Dynamics
5.1. Key Insights
5.2. Recent Developments
5.3. Market Drivers & Opportunities
5.4. Market Restraints & Challenges
5.5. Market Trends
5.6. Supply chain Analysis
5.7. Policy & Regulatory Framework
5.8. Industry Experts Views
6. United Kingdom Healthcare Fintech Market Overview
6.1. Market Size By Value
6.2. Market Size and Forecast, By Solution
6.3. Market Size and Forecast, By Economic Buyer
6.4. Market Size and Forecast, By Deployment Mode
6.5. Market Size and Forecast, By Payment Type
6.6. Market Size and Forecast, By Region
7. United Kingdom Healthcare Fintech Market Segmentations
7.1. United Kingdom Healthcare Fintech Market, By Solution
7.1.1. United Kingdom Healthcare Fintech Market Size, By Provider Revenue Cycle and Payment Fintech, 2020-2031
7.1.2. United Kingdom Healthcare Fintech Market Size, By Payer Claims and Payment Automation Fintech, 2020-2031
7.1.3. United Kingdom Healthcare Fintech Market Size, By Patient Care Financing, 2020-2031
7.1.4. United Kingdom Healthcare Fintech Market Size, By Health Insurance Premium Financing, 2020-2031
7.1.5. United Kingdom Healthcare Fintech Market Size, By Consumer-Directed Healthcare Accounts and Benefit Payment Platforms, 2020-2031
7.1.6. United Kingdom Healthcare Fintech Market Size, By Healthcare Financial Management and Working Capital Fintech, 2020-2031
7.2. United Kingdom Healthcare Fintech Market, By Economic Buyer
7.2.1. United Kingdom Healthcare Fintech Market Size, By Healthcare Providers, 2020-2031
7.2.2. United Kingdom Healthcare Fintech Market Size, By Healthcare Payers, 2020-2031
7.2.3. United Kingdom Healthcare Fintech Market Size, By Patients and Individual Consumers, 2020-2031
7.2.4. United Kingdom Healthcare Fintech Market Size, By Employers and Plan Sponsors, 2020-2031
7.3. United Kingdom Healthcare Fintech Market, By Deployment Mode
7.3.1. United Kingdom Healthcare Fintech Market Size, By Cloud-Based, 2020-2031
7.3.2. United Kingdom Healthcare Fintech Market Size, By On-Premises, 2020-2031
7.3.3. United Kingdom Healthcare Fintech Market Size, By Hybrid, 2020-2031
7.4. United Kingdom Healthcare Fintech Market, By Payment Type
7.4.1. United Kingdom Healthcare Fintech Market Size, By Patient-to-Provider Payments, 2020-2031
7.4.2. United Kingdom Healthcare Fintech Market Size, By Payer-to-Provider Payments, 2020-2031
7.4.3. United Kingdom Healthcare Fintech Market Size, By Business-to-Business (B2B) Healthcare Payments, 2020-2031
7.4.4. United Kingdom Healthcare Fintech Market Size, By Healthcare Benefit Account Payments and Reimbursements, 2020-2031
7.5. United Kingdom Healthcare Fintech Market, By Region
7.5.1. United Kingdom Healthcare Fintech Market Size, By North, 2020-2031
7.5.2. United Kingdom Healthcare Fintech Market Size, By East, 2020-2031
7.5.3. United Kingdom Healthcare Fintech Market Size, By West, 2020-2031
7.5.4. United Kingdom Healthcare Fintech Market Size, By South, 2020-2031
8. United Kingdom Healthcare Fintech Market Opportunity Assessment
8.1. By Solution, 2026 to 2031
8.2. By Economic Buyer, 2026 to 2031
8.3. By Deployment Mode, 2026 to 2031
8.4. By Payment Type, 2026 to 2031
8.5. By Region, 2026 to 2031
9. Competitive Landscape
9.1. Porter's Five Forces
9.2. Company Profile
9.2.1. Company 1
9.2.1.1. Company Snapshot
9.2.1.2. Company Overview
9.2.1.3. Financial Highlights
9.2.1.4. Geographic Insights
9.2.1.5. Business Segment & Performance
9.2.1.6. Product Portfolio
9.2.1.7. Key Executives
9.2.1.8. Strategic Moves & Developments
9.2.2. Company 2
9.2.3. Company 3
9.2.4. Company 4
9.2.5. Company 5
9.2.6. Company 6
9.2.7. Company 7
9.2.8. Company 8
10. Strategic Recommendations
11. Disclaimer
Table 1: Influencing Factors for Healthcare Fintech Market, 2025
Table 2: United Kingdom Healthcare Fintech Market Size and Forecast, By Solution (2020 to 2031F) (In USD Million )
Table 3: United Kingdom Healthcare Fintech Market Size and Forecast, By Economic Buyer (2020 to 2031F) (In USD Million )
Table 4: United Kingdom Healthcare Fintech Market Size and Forecast, By Deployment Mode (2020 to 2031F) (In USD Million )
Table 5: United Kingdom Healthcare Fintech Market Size and Forecast, By Payment Type (2020 to 2031F) (In USD Million )
Table 6: United Kingdom Healthcare Fintech Market Size and Forecast, By Region (2020 to 2031F) (In USD Million )
Table 7: United Kingdom Healthcare Fintech Market Size of Provider Revenue Cycle and Payment Fintech (2020 to 2031) in USD Million
Table 8: United Kingdom Healthcare Fintech Market Size of Payer Claims and Payment Automation Fintech (2020 to 2031) in USD Million
Table 9: United Kingdom Healthcare Fintech Market Size of Patient Care Financing (2020 to 2031) in USD Million
Table 10: United Kingdom Healthcare Fintech Market Size of Health Insurance Premium Financing (2020 to 2031) in USD Million
Table 11: United Kingdom Healthcare Fintech Market Size of Consumer-Directed Healthcare Accounts and Benefit Payment Platforms (2020 to 2031) in USD Million
Table 12: United Kingdom Healthcare Fintech Market Size of Healthcare Financial Management and Working Capital Fintech (2020 to 2031) in USD Million
Table 13: United Kingdom Healthcare Fintech Market Size of Healthcare Providers (2020 to 2031) in USD Million
Table 14: United Kingdom Healthcare Fintech Market Size of Healthcare Payers (2020 to 2031) in USD Million
Table 15: United Kingdom Healthcare Fintech Market Size of Patients and Individual Consumers (2020 to 2031) in USD Million
Table 16: United Kingdom Healthcare Fintech Market Size of Employers and Plan Sponsors (2020 to 2031) in USD Million
Table 17: United Kingdom Healthcare Fintech Market Size of Cloud-Based (2020 to 2031) in USD Million
Table 18: United Kingdom Healthcare Fintech Market Size of On-Premises (2020 to 2031) in USD Million
Table 19: United Kingdom Healthcare Fintech Market Size of Hybrid (2020 to 2031) in USD Million
Table 20: United Kingdom Healthcare Fintech Market Size of Patient-to-Provider Payments (2020 to 2031) in USD Million
Table 21: United Kingdom Healthcare Fintech Market Size of Payer-to-Provider Payments (2020 to 2031) in USD Million
Table 22: United Kingdom Healthcare Fintech Market Size of Business-to-Business (B2B) Healthcare Payments (2020 to 2031) in USD Million
Table 23: United Kingdom Healthcare Fintech Market Size of Healthcare Benefit Account Payments and Reimbursements (2020 to 2031) in USD Million
Table 24: United Kingdom Healthcare Fintech Market Size of North (2020 to 2031) in USD Million
Table 25: United Kingdom Healthcare Fintech Market Size of East (2020 to 2031) in USD Million
Table 26: United Kingdom Healthcare Fintech Market Size of West (2020 to 2031) in USD Million
Table 27: United Kingdom Healthcare Fintech Market Size of South (2020 to 2031) in USD Million
Figure 1: United Kingdom Healthcare Fintech Market Size By Value (2020, 2025 & 2031F) (in USD Million )
Figure 2: Market Attractiveness Index, By Solution
Figure 3: Market Attractiveness Index, By Economic Buyer
Figure 4: Market Attractiveness Index, By Deployment Mode
Figure 5: Market Attractiveness Index, By Payment Type
Figure 6: Market Attractiveness Index, By Region
Figure 7: Porter's Five Forces of United Kingdom Healthcare Fintech Market
United Kingdom Healthcare Fintech Market Research FAQs
Germany dominates the Europe Healthcare Fintech Market, accounting for approximately 19% of regional revenue, driven by its dual statutory-private insurance structure, 40.8 million private insurance contracts, and mature digital health infrastructure.
Patient Care Financing is the fastest-growing solution segment in Europe, supported by residual out-of-pocket costs, the expansion of embedded point-of-care credit, and the mainstreaming of patient financing platforms in Germany, France, and Austria.
Provider Revenue Cycle and Payment Fintech is the largest solution segment in Europe, driven by the scale of multi-payer reimbursement and the operational necessity of claims automation across statutory and private payer systems.
Cloud-Based deployment is the largest mode in Europe, reflecting the scalability requirements of mid-sized and smaller providers and the need to integrate with national e-invoicing and instant payment rails.
Healthcare Payers and Statutory Insurers represent the largest economic buyer group in Europe, reflecting the scale of statutory and complementary insurance expenditure and the obligation to automate claims and reimbursement.
Patients and Individual Consumers represent the fastest-growing economic buyer group in Europe, driven by residual out-of-pocket costs and the expansion of patient financing and premium financing.
The Europe Healthcare Fintech Market is expected to maintain its growth trajectory through the forecast period, supported by instant payments modernisation, mandatory e-invoicing, the European Health Data Space, and the expansion of embedded patient finance. Germany and France will remain the dominant markets, while the United Kingdom, Italy, Spain, and the Nordic countries offer significant growth opportunities as they digitise reimbursement infrastructure and address interoperability gaps.
Germany dominates the Europe Healthcare Fintech Market, accounting for approximately 19% of regional revenue, driven by its dual statutory-private insurance structure, 40.8 million private insurance contracts, and mature digital health infrastructure.
Patient Care Financing is the fastest-growing solution segment in Europe, supported by residual out-of-pocket costs, the expansion of embedded point-of-care credit, and the mainstreaming of patient financing platforms in Germany, France, and Austria.
Provider Revenue Cycle and Payment Fintech is the largest solution segment in Europe, driven by the scale of multi-payer reimbursement and the operational necessity of claims automation across statutory and private payer systems.
Cloud-Based deployment is the largest mode in Europe, reflecting the scalability requirements of mid-sized and smaller providers and the need to integrate with national e-invoicing and instant payment rails.
Healthcare Payers and Statutory Insurers represent the largest economic buyer group in Europe, reflecting the scale of statutory and complementary insurance expenditure and the obligation to automate claims and reimbursement.
Patients and Individual Consumers represent the fastest-growing economic buyer group in Europe, driven by residual out-of-pocket costs and the expansion of patient financing and premium financing.
The Europe Healthcare Fintech Market is expected to maintain its growth trajectory through the forecast period, supported by instant payments modernisation, mandatory e-invoicing, the European Health Data Space, and the expansion of embedded patient finance. Germany and France will remain the dominant markets, while the United Kingdom, Italy, Spain, and the Nordic countries offer significant growth opportunities as they digitise reimbursement infrastructure and address interoperability gaps.
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information